News

The clinical trial, which will enroll approximately 60 patients, is designed to evaluate the safety and efficacy of PT-141 in the “at-home” environment. It will entail a two

According to the company, infection with CMV, a member of the herpes virus group, averages between 50% and 85% of adults in the US by 40 years of

The company has selected Hong Kong-based South Asia Pharmamedic as its distribution partner in the People’s Republic of China and Hong Kong to help sell the pain relief

This was the third of several regularly scheduled reviews by the data safety monitoring board (DSMB) that will occur over the duration of the trial, in order to

The 28-day, phase II clinical study enrolled 12 treatment-naive patients with genotype 1 HCV. Patients received VX-950 in a tablet formulation at a dose of 750 mg every

The company will instead focus its resources on Invirase, a tablet formulation of the drug that offers a more convenient and tolerable treatment regimen for HIV positive patients.

The vaccine candidate is based on HIV subtype C, the most prevalent subtype of the virus in southern and eastern Africa, and was developed by Seattle based Targeted

The trial, the first study of bicifadine in patients with neuropathic pain, will randomize 50 patients with painful diabetic neuropathy into two parallel four-week treatment groups. The trial

This second study will compare the treatment of dexamethasone with Xerecept in patients already on low-dose steroid whose dose must be escalated to treat their symptoms. In November